Quantitative Susceptibility Mapping of the Hippocampal Fimbria in Alzheimer's Disease

Chun Ki Franklin Au1, Jill Abrigo1, Chunlei Liu2,3

  • 1Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China.

Abstract

Insights

Quantitative susceptibility mapping (QSM) reveals altered magnetic properties in the fimbria of Alzheimer's disease (AD) patients. This imaging technique can differentiate between healthy individuals and those with early-stage AD, aiding in diagnosis.

Area of Science:

  • Neuroimaging
  • Biomarkers
  • Neurodegenerative Diseases

Background:

  • Alzheimer's disease (AD) is characterized by hippocampal gray matter damage, but the role of the fimbria, a white matter tract, remains unclear.
  • AD-associated demyelination and iron deposition alter tissue magnetic properties, measurable by quantitative susceptibility mapping (QSM).

Purpose of the Study:

  • To investigate microstructural changes in the fimbria using QSM in individuals with and without Alzheimer's disease.
  • To determine if QSM can detect AD-related alterations in the fimbria and differentiate between disease stages.

Main Methods:

  • A retrospective cross-sectional study involving 53 adults (30 controls, 13 early AD, 10 late AD).
  • Quantitative susceptibility mapping (QSM) was performed using a 3T scanner with a 3D fast-field echo sequence.
  • Fimbrial segmentation and QSM value extraction (mean, median, min, max) were conducted on T1-weighted images.

Main Results:

  • Significant differences in mean and median QSM values were observed across control, early AD, and late AD groups (P < 0.05).
  • Fimbrial QSM values shifted from negative in controls to positive in AD patients.
  • QSM mean and median values accurately differentiated control and early AD subjects (AUC 0.744 and 0.782, respectively).

Conclusions:

  • The fimbria exhibits higher magnetic susceptibility in individuals with Alzheimer's disease compared to controls.
  • QSM is a promising imaging biomarker for detecting fimbrial changes in AD and may aid in early diagnosis.